Revolution Medicines, Inc. current report, 17 April 2020

Business Context and Reporting Period

Revolution Medicines, Inc. (RVMD), a Delaware corporation, filed this Form 8-K on April 17, 2020. The filing reports the entry into a material definitive agreement regarding the expansion of its principal executive offices located in Redwood City, California.

Key Financial Metrics and Obligations

This filing details lease obligations rather than operational financial performance metrics such as revenue or profit.

  • New Lease Space: 19,483 square feet at the "300 Building" (300 Saginaw Drive).
  • Existing Lease Space: Continued lease at the "700 Building" (700 Saginaw Drive).
  • 300 Building Rent: Approximately $1.2 million annual base rent until December 31, 2021, increasing by approximately 3.5% annually thereafter.
  • 700 Building Rent: Approximately $2.8 million for the 12-month period ending April 30, 2024, increasing by approximately 3.5% annually thereafter.
  • Rent Abatement: Six months of rent abatement for the 300 Building from January 1, 2021, through June 30, 2021.
  • Lease Term: Expires December 31, 2030, with an option to extend for an additional ten years.

Material Changes and Other Events

Effective April 17, 2020, the Company assumed a lease for the 300 Building expiring December 14, 2020, with a monthly rent of $62,495.62. Concurrently, the Company entered into a sublease agreement to sublease approximately 50% of the 300 Building, with an initial term expiring December 14, 2020. The Second Amendment to the Lease formalizes the long-term expansion of the Company's facilities.

Guidance, Outlook, and Risks

The filing does not provide financial guidance, management commentary on future performance, or specific risk factors beyond the standard disclosure that the summary of the lease terms is subject to the full agreement filed as an exhibit to the Form 10-Q. The filing indicates the Company is an emerging growth company.

Investor Verification Checklist

  • Verify the total square footage and specific location of the new 300 Building lease.
  • Confirm the start date of the new lease (December 15, 2020) and the rent abatement period.
  • Review the sublease agreement terms for the 50% portion of the 300 Building to understand net occupancy costs.
  • Check the upcoming Form 10-Q for the full text of the Second Amendment to the Lease.
  • Assess the impact of the increased fixed lease costs on the Company's cash burn rate given its pre-revenue status.